Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ePISTLE Study: Perceptions of Illness Severity, Treatment Goals and Life Expectancy

NCT04225416 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04225416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04225416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ePISTLE Study: Perceptions of Illness Severity, Treatment Goals and Life Expectancy
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Unknown status
Start date
November 16, 2018
Completion date
November 1, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, peritoneal dialysis